Description:
 
SS-31 (elamipretide) is a mitochondria-targeted tetrapeptide designed to enhance mitochondrial function. It selectively binds to cardiolipin, a phospholipid unique to the inner mitochondrial membrane, stabilizing mitochondrial structure and reducing reactive oxygen species (ROS) production. This mechanism supports improved ATP synthesis and cellular energy metabolism
 
Research Application:
 
Standard Protocol: 0.5–5 mg per administration
Frequency: Once daily
Route: Subcutaneous (Sub-Q) or Intraperitoneal (IP) injection
Duration: 2–4 weeks, depending on research objective
 
Availability:
Purity: ≥99%
Form: Lyophilized powder for reconstitution
 
Disclaimer:
The statements made on this website have not been evaluated by the US Food and Drug Administration. These are not findings from Raina's Summit, but instead publicly available studies. This product is for research purposes only.